Cyclooxygenase isoenzyme-2 and vascular endothelial growth factor are associated with poor prognosis in esophageal adenocarcinoma.

M.J.D. Prins; R.J.J. Verhage; F.J.W. ten Kate; R. van Hillegersberg

Cyclooxygenase isoenzyme-2 and vascular endothelial growth factor are associated with poor prognosis in esophageal adenocarcinoma.

Translated title of the contribution: Cyclooxygenase isoenzyme-2 and vascular endothelial growth factor are associated with poor prognosis in esophageal adenocarcinoma.

M.J.D. Prins, R.J.J. Verhage, F.J.W. ten Kate, R. van Hillegersberg

Research output: Contribution to journal › Article › Academic › peer-review

Translated title of the contribution	Cyclooxygenase isoenzyme-2 and vascular endothelial growth factor are associated with poor prognosis in esophageal adenocarcinoma.
Original language	Undefined/Unknown
Pages (from-to)	956-966
Number of pages	11
Journal	Journal of Gastrointestinal Surgery
Volume	16
Issue number	5
Publication status	Published - 2012

Access to Document

http://www.ncbi.nlm.nih.gov/pubmed/22258871

Cite this

@article{9643c904f52045fab70e4678e035b097,

title = "Cyclooxygenase isoenzyme-2 and vascular endothelial growth factor are associated with poor prognosis in esophageal adenocarcinoma.",

author = "M.J.D. Prins and R.J.J. Verhage and {ten Kate}, F.J.W. and {van Hillegersberg}, R.",

year = "2012",

language = "Undefined/Unknown",

volume = "16",

pages = "956--966",

journal = "Journal of Gastrointestinal Surgery",

issn = "1091-255X",

publisher = "Springer New York",

number = "5",

}

TY - JOUR

T1 - Cyclooxygenase isoenzyme-2 and vascular endothelial growth factor are associated with poor prognosis in esophageal adenocarcinoma.

AU - Prins, M.J.D.

AU - Verhage, R.J.J.

AU - ten Kate, F.J.W.

AU - van Hillegersberg, R.

PY - 2012

Y1 - 2012

M3 - Article

SN - 1091-255X

VL - 16

SP - 956

EP - 966

JO - Journal of Gastrointestinal Surgery

JF - Journal of Gastrointestinal Surgery

IS - 5

ER -